No definition available.
Chronic drug-induced interstitial lung disorders
CHRONIC_DRUGADVERS_INTERSTITIAL_LUNG_DISORD
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
52 |
4. Check minimum number of eventsNone |
52 |
5. Include endpointsNone |
52 |
6. Filter based on genotype QC (FinnGen only) |
52 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Chronic drug-induced interstitial lung disorders
based on the number of shared cases.
Similar with more cases:
- Respiratory conditions due to other external agents
- Lung diseases due to external agents
- Diagnoses used for exclusion with ILD
- Other pulmonary diagnosis
- Excluding asthma or asthma-COPD overlap
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 444 | 290 | 152 |
| Only index persons | 328 | 215 | 113 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 73.02 | 75.38 | 68.75 |
| Only index persons | 71.67 | 74.75 | 65.82 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 52 | 29 | 23 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 64.70 | 63.82 | 65.82 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
12
10.08
7.85
2.0
1.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
34
151
4.62
6.67
14.3
5.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
16
7.50
6.20
2.6
2.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
41
217
5.20
6.20
13.0
6.7
e9/l
0.0
0.0
0.41
34
196
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
19
58
4.59
6.02
2.6
2.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
29
122
4.11
5.96
11.9
9.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
41
223
4.96
5.83
14.4
6.8
e9/l
0.2
0.2
0.20
36
204
(3001604) Monocytes [#/volume] in Blood
40
218
4.62
5.56
13.3
6.6
e9/l
0.7
0.6
0.75
34
194
(3019198) Lymphocytes [#/volume] in Blood
40
223
4.44
5.27
13.4
6.5
e9/l
2.1
1.7
0.89
34
203
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
18
58
4.22
5.25
2.6
1.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
13
33
4.92
5.06
3.6
4.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
14
38
4.67
5.04
2.4
2.1
ng/l
267.4
122.6
0.52
14
30
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
12
33
4.43
4.20
10.8
7.3
mmol/l
24.6
24.9
0.12
12
33
(3000492) Spirometry study
12
33
4.43
4.20
2.0
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
30
157
3.15
3.97
6.1
4.8
ph
7.4
7.4
—
5
33
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
20
83
3.29
3.90
2.6
2.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
13
41
3.89
3.80
2.4
1.4
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
12
36
4.03
3.74
16.5
10.9
%
0.7
0.6
0.36
12
36
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
9
8.76
3.68
1.4
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
13
43
3.70
3.54
14.3
10.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
10
7.88
3.48
2.1
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
10
7.88
3.48
1.6
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
27
145
2.79
3.24
4.0
3.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
19
85
2.95
3.19
2.9
2.8
e6/l
0.6
3.8
1.21
11
46
(3009445) Proteinase 3 Ab [Units/volume] in Serum
9
21
4.95
3.16
1.3
1.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
27
148
2.71
3.08
7.4
4.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
5
10.86
3.04
3.0
1.4
e9/l
4.1
5.8
—
5
5
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
11
36
3.61
3.01
17.7
10.2
%
1.4
1.2
0.36
11
36
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
14
54
3.18
3.00
2.5
4.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
19
90
2.75
2.83
2.6
2.7
e6/l
1.0
0.8
0.16
11
50
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
14
5.59
2.83
2.7
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
31
189
2.59
2.77
4.5
3.3
—
—
—
0
0
(4010399)
9
25
4.13
2.72
1.7
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
15
5.21
2.70
2.7
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
11
6.00
2.62
3.5
2.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
11
6.00
2.62
1.3
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
7
7.74
2.60
3.0
2.0
%
57.0
52.7
—
5
7
(3031040) Bacteria [#/volume] in Urine by Automated count
41
294
2.87
2.52
10.1
5.1
—
97.9
—
0
8
(3020891) Body temperature
8
22
4.10
2.48
5.5
4.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
42
307
2.91
2.45
9.4
4.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
0
62
0.00
2.43
0.0
4.3
—
30.8
—
0
36
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
13
5.06
2.34
1.5
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
5
9
6.00
2.26
2.4
1.1
g/l
0.2
0.2
—
5
9
(3022217) INR in Platelet poor plasma by Coagulation assay
13
57
2.71
2.19
39.3
19.2
—
1.5
—
0
5
(3011397) Hemoglobin [Presence] in Urine by Test strip
19
102
2.36
2.12
6.3
3.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
32
3.18
2.12
2.3
2.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
10
5.40
2.12
1.6
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
5
10
5.40
2.12
2.4
1.1
g/l
1.1
1.1
—
5
10
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
10
5.40
2.12
1.2
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
10
5.40
2.12
3.2
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
13
59
2.60
2.04
1.9
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
10
40
2.86
1.97
2.1
5.0
e9/l
66.5
74.9
—
5
32
(3026008) Bacteria identified in Urine by Culture
25
156
2.16
1.93
6.6
3.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
35
250
2.22
1.90
15.4
7.4
mmol/l
1.2
1.2
0.04
30
208
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
12
4.48
1.87
3.2
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
18
3.62
1.80
1.5
4.0
—
—
—
0
0
(3013512) EKG study
8
164
0.40
1.78
4.3
4.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
14
71
2.33
1.74
3.2
2.3
g/l
2.4
2.3
0.23
14
61
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
28
188
2.06
1.74
2.0
2.1
pmol/l
81.4
99.0
1.00
15
88
(40760892) CBC W Ordered Manual Differential panel - Blood
17
97
2.12
1.59
7.4
6.4
—
—
—
0
0
(3012544) pH of Venous blood
11
53
2.36
1.51
1.3
3.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
31
224
1.95
1.49
8.8
6.3
estimate
0.0
0.0
—
9
45
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
6
23
2.81
1.41
2.2
3.3
%
0.5
0.8
—
6
23
(3009261) Glucose [Presence] in Urine by Test strip
31
227
1.91
1.40
6.5
4.5
estimate
0.0
0.0
—
8
46
(3021589) Normoblasts [#/volume] in Blood
29
210
1.86
1.34
22.1
13.0
e9/l
0.0
0.0
0.61
23
177
(3006184) Hemoglobin [Mass/volume] in Capillary blood
5
18
2.96
1.31
1.2
2.4
—
120.4
—
0
11
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
25
2.58
1.28
2.2
3.2
%
1.3
1.5
—
6
25
(3015736) pH of Urine
25
176
1.81
1.24
5.9
4.2
—
—
—
0
0
(3044889) 12 lead EKG panel
41
338
2.01
1.20
6.9
4.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
13
75
1.98
1.16
2.7
1.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
7
31
2.45
1.15
1.6
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
7
31
2.45
1.15
6.9
4.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
7
31
2.45
1.15
2.1
3.2
g/l
132.3
128.7
—
7
31
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
31
2.45
1.15
1.3
1.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
10
52
2.14
1.15
1.3
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
9
46
2.15
1.11
7.7
3.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
22
2.40
1.06
1.6
3.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
29
221
1.71
1.04
7.4
4.5
estimate
0.0
0.0
—
9
47
(4035726)
9
51
1.92
1.01
1.2
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
31
2.05
0.87
21.8
10.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
0
27
0.00
0.80
0.0
3.0
—
3.5
—
0
18
(40761511) CBC panel - Blood by Automated count
42
460
0.55
0.79
27.8
16.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
45
479
0.55
0.73
52.9
25.6
e9/l
7.8
6.6
1.57
45
463
(3000963) Hemoglobin [Mass/volume] in Blood
45
479
0.55
0.73
53.3
25.6
g/l
130.1
133.6
0.76
45
470
(3026361) Erythrocytes [#/volume] in Blood
45
479
0.55
0.73
52.9
25.5
e12/l
4.3
4.4
0.53
45
463
(3024731) MCV [Entitic volume]
45
479
0.55
0.73
52.8
25.4
fl
92.4
91.9
0.25
45
469
(3035941) MCH [Entitic mass]
45
479
0.55
0.73
52.8
25.3
pg
30.5
30.5
0.01
45
469
(3013707) Erythrocyte sedimentation rate by Westergren method
39
337
1.63
0.73
9.6
4.6
mm/h
16.5
12.6
0.97
39
303
(3007461) Platelets [#/volume] in Blood
45
478
0.57
0.72
53.0
25.5
e9/l
251.5
244.4
0.22
45
463
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
28
1.87
0.68
2.8
3.4
%
44.1
39.2
—
5
28
(3027273) Bicarbonate [Moles/volume] in Venous blood
5
29
1.80
0.65
2.4
3.2
mmol/l
24.9
25.1
—
5
29
(36660697) Celiac disease serology panel - Serum
5
29
1.80
0.65
1.0
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
14
98
1.59
0.65
4.4
2.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
42
375
1.62
0.62
46.5
21.7
%
14.8
14.0
1.56
42
368
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
20
0.00
0.62
0.0
1.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
0
20
0.00
0.62
0.0
4.5
—
0.1
—
0
10
(1761482) Bacteria [#/volume] in Urine by Culture
0
22
0.00
0.61
0.0
5.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
23
184
1.45
0.58
2.0
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
11
153
0.64
0.56
2.5
3.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
6
40
1.56
0.53
1.2
2.0
%
1.9
1.5
—
6
30
(3032080) INR in Blood by Coagulation assay
26
216
1.41
0.52
18.0
11.0
inr
1.2
1.3
—
9
74
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
45
471
0.67
0.48
28.2
12.1
u/l
24.0
24.6
0.13
45
454
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
8
58
1.45
0.44
1.0
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
16
0.00
0.42
0.0
1.7
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
16
0.00
0.42
0.0
1.4
—
47.8
—
0
16
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
17
0.00
0.41
0.0
1.9
—
—
—
0
0
(4034850)
0
17
0.00
0.41
0.0
7.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
5
35
1.47
0.40
9.2
3.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
7
54
1.34
0.32
1.3
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
25
221
1.25
0.28
2.6
2.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
41
384
1.32
0.27
50.3
18.6
%
38.9
39.2
0.12
28
253
(3041354) Potassium [Moles/volume] in Venous blood
0
11
0.00
0.21
0.0
2.5
—
4.0
—
0
11
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
11
0.00
0.21
0.0
2.5
—
107.8
—
0
11
(3008898) HLA-B27 [Presence]
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
12
0.00
0.21
0.0
2.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
14
0.00
0.20
0.0
4.2
—
26.9
—
0
7
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
6
51
1.20
0.20
1.3
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
23
207
1.20
0.20
5.6
4.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
45
461
0.82
0.19
42.4
20.8
umol/l
83.9
81.5
0.28
45
461
(3044640) Blood type and Crossmatch panel - Blood
16
140
1.21
0.18
5.3
2.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
31
328
0.86
0.14
4.6
4.3
pmol/l
15.3
15.0
0.21
26
287
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
19
173
1.15
0.13
8.6
4.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
16
144
1.16
0.12
2.9
4.2
mg/mmol
1.2
8.0
—
8
86
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5
44
1.15
0.10
1.0
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
15
136
1.14
0.10
2.9
3.3
mg/l
6.0
60.8
—
8
82
(3007853) Bacteria identified in Skin by Aerobe culture
5
46
1.10
0.10
2.4
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
5
47
1.07
0.10
1.4
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
14
130
1.11
0.05
5.6
4.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
11
118
0.91
0.03
1.5
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
13
123
1.08
0.02
12.2
4.7
estimate
0.0
0.0
—
8
47
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
12
125
0.95
0.00
2.8
5.0
%
18.6
21.4
—
5
66
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
0.5
—
0
6
(3006270) Folate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
418.5
—
0
6
(3004616) Nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
14.5
—
0
7
(4146454)
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
3.1
—
85.2
—
0
8
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
3.0
—
0
8
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CHRONIC_DRUGADVERS_INTERSTITIAL_LUNG_DISORD and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CHRONIC_DRUGADVERS_INTERSTITIAL_LUNG_DISORD | 2.051 [1.56, 2.7] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.297 |
During the follow-up period (1.1.1998 — 31.12.2019), 160 out of 262 females with CHRONIC_DRUGADVERS_INTERSTITIAL_LUNG_DISORD died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have CHRONIC_DRUGADVERS_INTERSTITIAL_LUNG_DISORD.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.17% | No data |
| 5 | 1.353% | No data |
| 10 | 3.344% | No data |
| 15 | 6.493% | No data |
| 20 | 11.182% | No data |
Relationships between endpoints
↥Index endpoint: CHRONIC_DRUGADVERS_INTERSTITIAL_LUNG_DISORD – Chronic drug-induced interstitial lung disorders
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data